山東路橋(000498.SZ)正籌劃收購山東省路橋集團17.11%股權 明起停牌
格隆匯12月9日丨山東路橋(000498.SZ)公佈,公司正在籌劃發行股份購買資產事項,同時募集配套資金。此次交易預計不構成重大資產重組,發行股份購買資產事項需按照《上市公司重大資產重組管理辦法》規定履行相關程序。
公司擬以發行股份購買資產方式收購鐵發基金和光大金甌持有的標的股權山東省路橋集團有限公司17.11%股權,鐵發基金和光大金甌擬同意上述收購,最終發行股份購買標的股權的數額以雙方正式簽署的股權收購協議為準。
經公司申請,公司證券自2019年12月10日開市時起開始停牌,預計停牌時間不超過5個交易日。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.